Summary:
- The article discusses the FDA's approval of Tonmya, a new medication for treating fibromyalgia, a chronic pain condition.
- Tonmya, also known as TNX-102 SL, is a sublingual (under-the-tongue) formulation of cyclobenzaprine, a muscle relaxant that has been used off-label to manage fibromyalgia symptoms.
- The approval of Tonmya provides a new treatment option for individuals living with fibromyalgia, which can help alleviate the widespread pain, fatigue, and other symptoms associated with this condition.